Interruption of natalizumab therapy for multiple sclerosis: what are the risks?
- PMID: 21543735
- DOI: 10.1212/WNL.0b013e31821d7553
Interruption of natalizumab therapy for multiple sclerosis: what are the risks?
Comment on
-
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.Neurology. 2011 May 31;76(22):1858-65. doi: 10.1212/WNL.0b013e31821e7c8a. Epub 2011 May 4. Neurology. 2011. PMID: 21543733
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources